The Egyptian HCV epidemic, and the country’s response to it, are unlike any other
country to date. Egypt has a very high burden of infection and disease: Egypt ranks
5th amongst all countries for the burden of disease from viral hepatitis,
[1]
close to 15% of the adult population are seropositive for HCV and over four million
individuals remain viraemic.
2
,
3
As a lower middle-income country, Egypt is relatively poor with a gross national
income per capita of $3,410 in 2016 according to the World Bank. Yet, it has strong
political backing to tackle the HCV epidemic, stemming in part from the role of a
national schistosomiasis programme in spreading the epidemic.
[5]
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of HepatologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.Lancet. 2016; 388: 1081-1088
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.Lancet Gastroenterol Hepatol. 2017; 2: 161-176
- The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment.Liver Int. 2017; 37: 45-53
- How to optimize HCV treatment impact on life years saved in resource-constrained countries.Hepatology. 2015; 62: 31-39
- Hepatitis C in Egypt – past, present, and future.Int J Gen Med. 2017; 10: 1-6
- Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case.J Viral Hepat. 2016; 23: 767-779
- Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010–2015.J Hepatol. 2017; 67: 15-22
- Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania.J Int AIDS Soc. 2017; 20: 21856
Article info
Publication history
Published online: February 03, 2018
Accepted:
January 25,
2018
Received:
January 21,
2018
See Article, pages 691–698Identification
Copyright
© 2018 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.
